Titre : Biguanides

Biguanides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Biguanides : Questions médicales les plus fréquentes", "headline": "Biguanides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Biguanides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-17", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Biguanides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Guanidines", "url": "https://questionsmedicales.fr/mesh/D006146", "about": { "@type": "MedicalCondition", "name": "Guanidines", "code": { "@type": "MedicalCode", "code": "D006146", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.078.370" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Buformine", "alternateName": "Buformin", "url": "https://questionsmedicales.fr/mesh/D002026", "about": { "@type": "MedicalCondition", "name": "Buformine", "code": { "@type": "MedicalCode", "code": "D002026", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.078.370.141.075" } } }, { "@type": "MedicalWebPage", "name": "Chlorhexidine", "alternateName": "Chlorhexidine", "url": "https://questionsmedicales.fr/mesh/D002710", "about": { "@type": "MedicalCondition", "name": "Chlorhexidine", "code": { "@type": "MedicalCode", "code": "D002710", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.078.370.141.100" } } }, { "@type": "MedicalWebPage", "name": "Metformine", "alternateName": "Metformin", "url": "https://questionsmedicales.fr/mesh/D008687", "about": { "@type": "MedicalCondition", "name": "Metformine", "code": { "@type": "MedicalCode", "code": "D008687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.078.370.141.450" } } }, { "@type": "MedicalWebPage", "name": "Phenformine", "alternateName": "Phenformin", "url": "https://questionsmedicales.fr/mesh/D010629", "about": { "@type": "MedicalCondition", "name": "Phenformine", "code": { "@type": "MedicalCode", "code": "D010629", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.078.370.141.700" } } }, { "@type": "MedicalWebPage", "name": "Proguanil", "alternateName": "Proguanil", "url": "https://questionsmedicales.fr/mesh/D002727", "about": { "@type": "MedicalCondition", "name": "Proguanil", "code": { "@type": "MedicalCode", "code": "D002727", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.078.370.141.710" } } } ], "about": { "@type": "MedicalCondition", "name": "Biguanides", "alternateName": "Biguanides", "code": { "@type": "MedicalCode", "code": "D001645", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Liam Good", "url": "https://questionsmedicales.fr/author/Liam%20Good", "affiliation": { "@type": "Organization", "name": "Pathobiology and Population Sciences, The Royal Veterinary College, London, England." } }, { "@type": "Person", "name": "Alan A Rogers", "url": "https://questionsmedicales.fr/author/Alan%20A%20Rogers", "affiliation": { "@type": "Organization", "name": "Flintshire, North Wales, UK." } }, { "@type": "Person", "name": "Manuel D Gahete", "url": "https://questionsmedicales.fr/author/Manuel%20D%20Gahete", "affiliation": { "@type": "Organization", "name": "Maimonides Institute for Biomedical Research of Cordoba, Córdoba, Spain." } }, { "@type": "Person", "name": "Justo P Castaño", "url": "https://questionsmedicales.fr/author/Justo%20P%20Casta%C3%B1o", "affiliation": { "@type": "Organization", "name": "Maimonides Institute for Biomedical Research of Cordoba, Córdoba, Spain." } }, { "@type": "Person", "name": "Raúl M Luque", "url": "https://questionsmedicales.fr/author/Ra%C3%BAl%20M%20Luque", "affiliation": { "@type": "Organization", "name": "Maimonides Institute for Biomedical Research of Cordoba, Córdoba, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Risk factors for jaw osteoradionecrosis: a case control study.", "datePublished": "2022-11-11", "url": "https://questionsmedicales.fr/article/36383838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1807-3107bor-2022.vol36.0132" } }, { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Amidines", "item": "https://questionsmedicales.fr/mesh/D000578" }, { "@type": "ListItem", "position": 4, "name": "Guanidines", "item": "https://questionsmedicales.fr/mesh/D006146" }, { "@type": "ListItem", "position": 5, "name": "Biguanides", "item": "https://questionsmedicales.fr/mesh/D001645" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Biguanides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Biguanides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Biguanides", "description": "Comment diagnostiquer le diabète de type 2 ?\nQuels tests sont utilisés pour évaluer la résistance à l'insuline ?\nQuels symptômes indiquent un diabète non contrôlé ?\nComment évaluer l'efficacité des biguanides ?\nQuels sont les critères de diagnostic du diabète ?", "url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Biguanides", "description": "Quels sont les effets secondaires des biguanides ?\nComment reconnaître une hypoglycémie ?\nQuels symptômes peuvent indiquer une acidose lactique ?\nQuels signes indiquent une mauvaise gestion du diabète ?\nComment les biguanides affectent-ils l'appétit ?", "url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Biguanides", "description": "Comment prévenir le diabète de type 2 ?\nQuels facteurs de risque sont modifiables ?\nComment le poids corporel influence-t-il le diabète ?\nQuel rôle joue l'activité physique dans la prévention ?\nLes contrôles médicaux réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Biguanides", "description": "Comment les biguanides agissent-ils ?\nQuels sont les principaux biguanides utilisés ?\nQuand commencer un traitement par biguanides ?\nQuels sont les dosages habituels de metformine ?\nLes biguanides peuvent-ils être combinés avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Biguanides", "description": "Quelles sont les complications du diabète mal contrôlé ?\nComment prévenir les complications liées au diabète ?\nQuels sont les signes d'une neuropathie diabétique ?\nComment le diabète affecte-t-il la santé rénale ?\nQuels examens sont nécessaires pour surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Biguanides", "description": "Quels sont les principaux facteurs de risque du diabète ?\nL'hérédité joue-t-elle un rôle dans le diabète ?\nComment le stress influence-t-il le diabète ?\nLe tabagisme est-il un facteur de risque ?\nQuel impact a l'alimentation sur le risque de diabète ?", "url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le diabète de type 2 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests de glycémie, comme la glycémie à jeun ou l'HbA1c." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la résistance à l'insuline ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le test de tolérance au glucose et l'indice HOMA-IR sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un diabète non contrôlé ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent soif excessive, urination fréquente et fatigue persistante." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des biguanides ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par la réduction de la glycémie et l'amélioration de l'HbA1c." } }, { "@type": "Question", "name": "Quels sont les critères de diagnostic du diabète ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent une glycémie à jeun ≥ 7 mmol/L ou HbA1c ≥ 6,5%." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des biguanides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des douleurs abdominales." } }, { "@type": "Question", "name": "Comment reconnaître une hypoglycémie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent tremblements, sueurs, confusion et palpitations." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une acidose lactique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue extrême, douleurs musculaires et respiration rapide." } }, { "@type": "Question", "name": "Quels signes indiquent une mauvaise gestion du diabète ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des infections fréquentes, des plaies qui guérissent lentement et des troubles de la vision." } }, { "@type": "Question", "name": "Comment les biguanides affectent-ils l'appétit ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les biguanides peuvent réduire l'appétit, contribuant ainsi à la perte de poids chez certains patients." } }, { "@type": "Question", "name": "Comment prévenir le diabète de type 2 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice régulier, aide à prévenir le diabète." } }, { "@type": "Question", "name": "Quels facteurs de risque sont modifiables ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le manque d'activité physique et une alimentation déséquilibrée sont modifiables." } }, { "@type": "Question", "name": "Comment le poids corporel influence-t-il le diabète ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un excès de poids augmente la résistance à l'insuline, augmentant le risque de diabète." } }, { "@type": "Question", "name": "Quel rôle joue l'activité physique dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'activité physique régulière améliore la sensibilité à l'insuline et aide à contrôler le poids." } }, { "@type": "Question", "name": "Les contrôles médicaux réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers aident à détecter précocement le diabète et à gérer les risques." } }, { "@type": "Question", "name": "Comment les biguanides agissent-ils ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Ils diminuent la production de glucose par le foie et augmentent la sensibilité à l'insuline." } }, { "@type": "Question", "name": "Quels sont les principaux biguanides utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La metformine est le biguanide le plus couramment prescrit pour le diabète de type 2." } }, { "@type": "Question", "name": "Quand commencer un traitement par biguanides ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement commence généralement après un diagnostic de diabète de type 2 et un échec des changements de mode de vie." } }, { "@type": "Question", "name": "Quels sont les dosages habituels de metformine ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les doses varient de 500 mg à 2000 mg par jour, selon la tolérance et la réponse du patient." } }, { "@type": "Question", "name": "Les biguanides peuvent-ils être combinés avec d'autres médicaments ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être combinés avec d'autres antidiabétiques pour un meilleur contrôle glycémique." } }, { "@type": "Question", "name": "Quelles sont les complications du diabète mal contrôlé ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies cardiovasculaires, des neuropathies et des problèmes rénaux." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au diabète ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Un bon contrôle glycémique et des examens réguliers aident à prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les signes d'une neuropathie diabétique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des picotements, des engourdissements et des douleurs dans les membres." } }, { "@type": "Question", "name": "Comment le diabète affecte-t-il la santé rénale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète peut entraîner une néphropathie, affectant la fonction rénale et provoquant des complications." } }, { "@type": "Question", "name": "Quels examens sont nécessaires pour surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers de la fonction rénale, des pieds et des yeux sont essentiels." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du diabète ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, l'âge avancé, l'hérédité et le mode de vie sédentaire." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans le diabète ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un antécédent familial de diabète augmente le risque de développer la maladie." } }, { "@type": "Question", "name": "Comment le stress influence-t-il le diabète ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut affecter la glycémie et la gestion du diabète, augmentant le risque de complications." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de diabète et de complications cardiovasculaires." } }, { "@type": "Question", "name": "Quel impact a l'alimentation sur le risque de diabète ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en sucres et en graisses saturées augmente le risque de diabète." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...